" /> B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 - CISMeF





Preferred Label : B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1;

NCIt synonyms : B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1); B Lymphoblastic Leukemia Lymphoma with t 12-21 p13 q22 TEL-AML1 ETV6-RUNX1; B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1); B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6::RUNX1; B Lymphoblastic Leukemia/Lymphoma with ETV6-RUNX1 Fusion; B-Lymphoblastic Leukemia/Lymphoma with ETV6-RUNX1 Fusion; B Lymphoblastic Leukemia/Lymphoma with ETV6::RUNX1 Fusion; B-Lymphoblastic Leukemia/Lymphoma with ETV6::RUNX1 Fusion;

NCIt definition : A precursor lymphoid neoplasm which is composed of B lymphoblasts and carries a translocation between the TEL gene on chromosome 12 and the AML1 gene on chromosome 21, (p13.2;q22.1). It results in the production of the TEL-AML1 (ETV6-RUNX1) fusion protein. It has a favorable clinical outcome.;

Neoplastic status : Malignant;

ICD-O code : 9814/3;

Détails


Vous pouvez consulter :


Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.